Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11


Decreased IL-8 levels in CSF and serum of AD patients and negative correlation of MMSE and IL-1β.

Hesse R, Wahler A, Gummert P, Kirschmer S, Otto M, Tumani H, Lewerenz J, Schnack C, von Arnim CA.

BMC Neurol. 2016 Sep 26;16(1):185.


Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.

Jiménez-Jiménez FJ, Alonso-Navarro H, García-Martín E, Agúndez JA.

Front Cell Neurosci. 2014 Nov 11;8:369. doi: 10.3389/fncel.2014.00369. eCollection 2014. Review.


Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.

Brosseron F, Krauthausen M, Kummer M, Heneka MT.

Mol Neurobiol. 2014 Oct;50(2):534-44. doi: 10.1007/s12035-014-8657-1. Epub 2014 Feb 25. Review.


Assessing candidate serum biomarkers for Alzheimer's disease: a longitudinal study.

Zabel M, Schrag M, Mueller C, Zhou W, Crofton A, Petersen F, Dickson A, Kirsch WM.

J Alzheimers Dis. 2012;30(2):311-21. doi: 10.3233/JAD-2012-112012.


CSF Biomarkers for Alzheimer's Disease Diagnosis.

Anoop A, Singh PK, Jacob RS, Maji SK.

Int J Alzheimers Dis. 2010 Jun 23;2010. pii: 606802. doi: 10.4061/2010/606802.


Biomarkers of oxidative damage and inflammation in Alzheimer's disease.

Galasko D, Montine TJ.

Biomark Med. 2010 Feb;4(1):27-36. doi: 10.2217/bmm.09.89. Review.


Neurochemical approaches in the laboratory diagnosis of Parkinson and Parkinson dementia syndromes: a review.

Jesse S, Steinacker P, Lehnert S, Gillardon F, Hengerer B, Otto M.

CNS Neurosci Ther. 2009 Summer;15(2):157-82. doi: 10.1111/j.1755-5949.2008.00064.x. Epub 2009 Mar 9. Review.


Urinary alpha1-antichymotrypsin: a biomarker of prion infection.

Miele G, Seeger H, Marino D, Eberhard R, Heikenwalder M, Stoeck K, Basagni M, Knight R, Green A, Chianini F, Wüthrich RP, Hock C, Zerr I, Aguzzi A.

PLoS One. 2008;3(12):e3870. doi: 10.1371/journal.pone.0003870. Epub 2008 Dec 5.


Biomarkers of Alzheimer's disease.

Craig-Schapiro R, Fagan AM, Holtzman DM.

Neurobiol Dis. 2009 Aug;35(2):128-40. doi: 10.1016/j.nbd.2008.10.003. Epub 2008 Oct 28. Review.


Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease.

Aluise CD, Sowell RA, Butterfield DA.

Biochim Biophys Acta. 2008 Oct;1782(10):549-58. doi: 10.1016/j.bbadis.2008.07.008. Epub 2008 Aug 7. Review.


Biomarkers for cognitive impairment and dementia in elderly people.

Sonnen JA, Montine KS, Quinn JF, Kaye JA, Breitner JC, Montine TJ.

Lancet Neurol. 2008 Aug;7(8):704-14. doi: 10.1016/S1474-4422(08)70162-5. Review.

Supplemental Content

Support Center